Literature DB >> 2122100

Vigabatrin in the treatment of glutaric aciduria type I.

B Francois1, J Jaeken, P Gillis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122100     DOI: 10.1007/bf01799393

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  5 in total

1.  Glutaric aciduria: inherited deficiency of glutaryl-CoA dehydrogenase activity.

Authors:  S I Goodman; J G Kohlhoff
Journal:  Biochem Med       Date:  1975-06

2.  Hypothesis: a role for quinolinic acid in the neuropathology of glutaric aciduria type I.

Authors:  M P Heyes
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

3.  Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and beta-hydroxyglutarate: explanation of the symptoms in glutaric aciduria?

Authors:  O Stokke; S I Goodman; P G Moe
Journal:  Clin Chim Acta       Date:  1976-02-02       Impact factor: 3.786

4.  Artifactual increases in the concentration of free GABA in samples of human cerebrospinal fluid are due to degradation of homocarnosine.

Authors:  J Grove; P J Schechter; G Tell; L Rumbach; C Marescaux; J M Warter; J Koch-Weser
Journal:  J Neurochem       Date:  1982-10       Impact factor: 5.372

5.  Glutaric aciduria: biochemical and morphologic considerations.

Authors:  S I Goodman; M D Norenberg; R H Shikes; D J Breslich; P G Moe
Journal:  J Pediatr       Date:  1977-05       Impact factor: 4.406

  5 in total
  2 in total

Review 1.  Maintenance treatment of glutaryl-CoA dehydrogenase deficiency.

Authors:  C Mühlhausen; G F Hoffmann; K A Strauss; S Kölker; J G Okun; C R Greenberg; E R Naughten; K Ullrich
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Macrocephaly, dystonia, and bilateral temporal arachnoid cysts: glutaric aciduria type 1.

Authors:  J F Martínez-Lage; C Casas; M A Fernández; A Puche; T Rodriguez Costa; M Poza
Journal:  Childs Nerv Syst       Date:  1994-04       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.